Filter
516
Filtered Results: 516
Text search:
biontech
Featured
Recommendations
61
New Publications
77
Language
Document type
No document type
160
Studies & Reports
118
Guidelines
105
Fact sheets
52
Manuals
37
Strategic & Response Plan
16
Training Material
7
Situation Updates
6
Infographics
6
Resource Platforms
4
Online Courses
3
Brochures
1
Videos
1
Countries / Regions
India
42
Global
21
Germany
19
Brazil
13
South Africa
11
Russia
11
Nepal
10
Ukraine
10
Latin America and the Carribbean
9
Argentina
9
Mozambique
8
Africa
7
Middle East and North Africa
7
Rwanda
5
Bangladesh
5
Nigeria
4
West and Central Africa
4
Western and Central Europe
4
Paraguay
4
Zambia
4
Colombia
3
Kenya
3
China
3
Chile
3
Cameroon
3
South–East Asia Region
3
East and Southern Africa
3
Uganda
3
Ethiopia
3
Ecuador
3
Myanmar / Burma
3
Thailand
2
Syria
2
Senegal
2
Peru
2
Malawi
2
Zimbabwe
2
Philippines
2
USA
2
Asia
2
Tanzania
2
Spain
2
Vietnam
2
Namibia
2
Angola
2
Botswana
2
El Salvador
1
Turkey
1
Ghana
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Iran
1
Afghanistan
1
Guinea
1
Haiti
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
Eastern Europe and Central Asia
1
France
1
United Kingdom
1
Portugal
1
Belarus
1
Southern Africa
1
Papua New Guinea
1
Sudan
1
Yemen
1
Central African Republic
1
Libya
1
South Sudan
1
Iraq
1
Somalia
1
Liberia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
198
Clinical Guidelines
32
Pharmacy & Technologies
21
Key Resources
18
Women & Child Health
8
Public Health
5
Capacity Building
1
Annual Report MEDBOX
1
Toolboxes
COVID-19
179
AMR
32
Rapid Response
24
TB
23
Planetary Health
23
HIV
18
Pharmacy
17
Refugee
16
NTDs
15
Ebola
12
Health Financing Toolbox
8
Global Health Education
7
Cholera
6
Social Ethics
6
Caregiver
6
Mental Health
5
Conflict
5
NCDs
4
Specific Hazards
3
Disability
2
Zika
1
Polio
1
Original text from 2008, updated in 2012. This document marks the beginning of a structured approach to safety assessment of GE foods, which are yet to be approved in our country. It is understood that many changes will become necessary and will be incorporated as we progress. This document will ho...
F.No. INDO/FRC/442/2008-IHD | INDIAN COUNCIL OF MEDICAL RESEARCH
| New Delhi, the 1st July, 2014 | OFFICE MEMORANDUM
Презентация на тему диагностики туберкулеза
Countries who have no testing capacity can send their samples to the WHO appointed 2019-nCoV referral laboratories for testing. National 2019-nCoV laboratories with limited experience are encouraged to send the first five positives and the first ten negative 2019-nCoV samples to their referral labor...
The threat posed by antimicrobial resistance (AMR) to public health as well as global health security has been reiterated in umerous World Health Assembly (WHA) resolutions. AMR is also prioritized under the Global Health Security Agenda (GHSA), and India is one of the contributing countries. The Mi...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
As of December 2018, CEPI has secured more than USD $747million towards its USD $1billion funding target, with financial support provided by the Bill & Melinda Gates Foundation, the Wellcome Trust, the European Commission, and the governments of Australia, Belgium, Canada, Germany, Japan, Norway, an...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
Wird ständig aktualisiert
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
Diese Faktenboxen sollen Ihnen helfen, Nutzen und Schaden einer Schutzimpfung gegen COVID-19 abzuwägen. Die Informationen und Zahlen stellen keine endgültige Bewertung dar. Sie basieren auf den derzeit besten wissenschaftlichen Erkenntnissen.
